National Employer Selects Dario Cardiometabolic And GLP-1 Solutions To Improve Employee Health
Portfolio Pulse from Benzinga Newsdesk
DarioHealth Corp. (NASDAQ:DRIO) has secured a contract to provide cardiometabolic and GLP-1 solutions to a national logistics employer starting January 2024. The solutions aim to support employees with diabetes, pre-diabetes, hypertension, and those on GLP-1 medication. Dario's approach integrates technology and expert support, leveraging data insights for personalized experiences. The GLP-1 solution includes FDA-required behavior change support and a Medication Cabinet for tracking adherence.
December 05, 2023 | 1:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DarioHealth Corp. has announced a new contract with a national employer to provide digital health solutions for employees with diabetes and hypertension, indicating potential growth in its client base and revenue.
The announcement of a new contract with a national employer is a positive development for DarioHealth, suggesting an expansion of its client base and potential increase in revenue. This news is likely to be viewed favorably by investors, as it demonstrates the company's ability to secure significant contracts and may lead to improved financial performance in the future.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100